Brooks Laboratories Ltd.

Name: Brooks Laboratories Ltd. Share Price Today, Stock Analysis
Brand: Brooks Laboratories Ltd.

Stock Card

NSE: BROOKS | BSE: 533543

₹67.05

₹-1.50 (-2.19%)

As on 02-Jun-2026IST

Market cap

₹197 Cr

Revenue (TTM)

₹89 Cr

P/E Ratio

9.1

P/B Ratio

1.7

Div. Yield

0 %

Brooks Lab Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 65.13 High: 71.90

52 Week Range

Low: 36.30 High: 164.02

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

₹22 Cr
ROE

-12.2 %
ROCE

-10 %
Industry P/E

32.93
EV/EBITDA

21.8
Debt to Equity

0.1
Book Value

₹39.4
EPS

₹7.3
Face value

10
Shares outstanding

29,457,248

10 Years Aggregate

CFO

₹-57.58 Cr

EBITDA

₹-40.83 Cr

Net Profit

₹-139.99 Cr

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Brooks Lab	-16.3	19.8	-0.1	-53.2	3.8	-6.6	0.1
BSE Healthcare	6.6	3.7	5.4	8.6	24.7	13.5	11.8

As on 02-Jun-2026

Company	2025	2024	2023	2022	2021	2020	2019
Brooks Lab	-56.4	23.4	32.6	8.9	43.9	170.4	-51.6
BSE Small Cap	-6.6	29.0	47.5	-1.8	62.8	32.1	-6.8
BSE Healthcare	-3.3	43.1	37.0	-12.1	20.9	61.4	-3.5

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price (₹)	Market Cap (₹ Cr)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Brooks Lab	67.1	196.6	88.9	6.5	7.2	20.2	9.1	1.7
Ajanta Pharma	2,912.2	36,428.7	5,452.9	1,056.0	22.4	23.9	34.5	8.0
Astrazeneca Pharma	8,710.0	21,797.6	2,275.6	187.5	10.3	22.9	116.2	25.0
Caplin Point Lab	1,988.1	15,100.9	2,187.2	649.7	31.5	19	23.5	4.2
CORONA Remedies	1,700.5	10,386.5	1,196.4	149.4	--	27.5	56.1	13.9
Eris Lifesciences	1,362.1	18,856.2	3,129.4	647.4	26.9	18.1	30.4	4.8
JB Chemicals	2,129.6	34,159.7	4,147.8	709.5	22.3	19.1	48.1	8.2
Pfizer	4,514.5	20,695.8	2,519.7	722.4	33.6	18.8	28.6	4.9
Procter & Gamble Health	6,030.5	10,005.3	1,408.0	326.9	30.8	57.1	30.6	19.1
Strides Pharma	1,075.0	9,915.5	4,858.7	574.1	14.9	19.7	17.8	3.2

Shareholding Pattern

View Details

News & Analysis

All News

No Review & Analysis are available.

About Brooks Lab

Brooks Laboratories Limited provides contract development and manufacturing services for pharmaceutical companies in India and internationally. The company's product portfolio includes liquid injection ampoules and vials, dry powder injection vials,... lyophilized injections, eye/ear drops, and nasal drops; B-Lactam and cephalosporin tablets, dry powder syrups, and injections; general, liquid, and dry powder injections; formulations for antibiotics, pain management, and controlled drugs; and oncology products and hormonal injections, etc. It also provides regulatory compliance, custom branding and packaging, scalable production, and end-to-end support services. The company serves government health programs and public sector institutions, hospitals and medical colleges, defense and railways, corporate healthcare, and NGOs. It exports its products to Afghanistan, Yemen, Kosovo, Bolivia, Guatemala, Turkmenistan Nigeria, Lebanon, Mauritius, Sudan, Madagascar, DR Congo, Mozambique, LATAM, and Africa. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India. Read more